Search

Your search keyword '"García-Samaniego, Javier"' showing total 410 results

Search Constraints

Start Over You searched for: Author "García-Samaniego, Javier" Remove constraint Author: "García-Samaniego, Javier"
410 results on '"García-Samaniego, Javier"'

Search Results

1. Programa de certificación de Centros de Adicciones para la eliminación del virus de la hepatitis C en España. Proyecto HepCelentes

2. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

3. Characterizing Hepatitis Delta in Spain and the gaps in its management

4. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

5. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

6. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

7. Recomendaciones para el diagnóstico integral de las hepatitis virales crónicas en una única extracción analítica

9. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

12. Real‐life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.

14. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

15. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH

16. Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

17. Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review

18. Eliminación de la hepatitis C. Documento de posicionamiento de la Asociación Española para el Estudio del Hígado (AEEH)

19. Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

21. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

22. Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain

23. Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

24. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

25. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

26. Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells

27. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

28. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

29. Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

31. High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain

32. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

33. Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

34. Programa de certificación de Centros de Adicciones para la eliminación del virus de la hepatitis C en España. Proyecto HepCelentes

35. Recomendaciones para el diagnóstico integral de las hepatitis virales crónicas en una única extracción analítica

37. High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

40. Global multi-stakeholder endorsement of the MAFLD definition

41. Global multi-stakeholder endorsement of the MAFLD definition

43. Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

45. Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities

47. Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world

49. One‐quarter of chronic hepatitis D patients reach HDV‐RNA decline or undetectability during the natural course of the disease

50. Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review

Catalog

Books, media, physical & digital resources